{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:12:53Z","timestamp":1747800773166,"version":"3.41.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clindermatol.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:54:10Z","timestamp":1743555250000},"page":"386-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tuberculosis and psoriasis: Is there a link between them?"],"prefix":"10.1016","volume":"43","author":[{"given":"Nikolai","family":"Tsankov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Grozdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.03.017_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0002","first-page":"39","article-title":"Biologic treatments of psoriasis: an update for the clinicians","volume":"15","author":"Brownstone","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/747204","article-title":"Psoriatic disease and tuberculosis nowadays","volume":"2012","author":"Balato","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0004","unstructured":"World Health Organization. Tuberculosis. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed March 14, 2025."},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-3083.2010.03730.x","article-title":"Economic burden of comorbidities in patients with psoriasis is substantial","volume":"25","author":"Kimball","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2012.12.966","article-title":"Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan","volume":"69","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0007","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/bjd.13539","article-title":"Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry","volume":"172","author":"Gisondi","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0009","first-page":"5591","article-title":"Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China","volume":"12","author":"Li","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"4 suppl","key":"10.1016\/j.clindermatol.2025.03.017_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.chest.2016.08.210","article-title":"TB risk in patients with biological therapy for psoriasis","volume":"150","author":"Fildan","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000337145","article-title":"Reactivation of tuberculosis in three cases of psoriasis after initiation of anti-TNF therapy","volume":"4","author":"Shaikha","year":"2012","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0012","first-page":"120","article-title":"Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report","volume":"90","author":"Skroza","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cid\/ciw778","article-title":"Official Thoracic Society\/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0014","first-page":"57","article-title":"Pruritus: advances in treatment","volume":"6","author":"Bernhard","year":"1991","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/09546639209089062","article-title":"Rifampicin therapy in severe forms of psoriasis","volume":"3","author":"Tsankov","year":"1992","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0016","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0190-9622(08)82050-6","article-title":"On rifampin treatment of psoriasis [letter]","volume":"29","author":"Tsankov","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0017","first-page":"78","article-title":"Rifampicin und psoriasis","volume":"23","author":"Kazandjieva","year":"1997","journal-title":"Act Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09546630500375643","article-title":"Old drug\u2013new indication","volume":"17","author":"Tsankov","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0019","first-page":"5","article-title":"Alternative treatment of psoriasis \u2013 is rifampicin a mild immunosuppressor?","volume":"2","author":"Grozdev","year":"2010","journal-title":"Serb J Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/09546630903496975","article-title":"Rifampicin\u2013a mild immunosuppressive agent for psoriasis","volume":"22","author":"Tsankov","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1468-3083.2008.02721.x","article-title":"Rifampicin in the treatment of psoriasis","volume":"23","author":"Tsankov","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0022","doi-asserted-by":"crossref","DOI":"10.5070\/D3205022617","article-title":"Improvement in severe psoriasis associated with isoniazid treatment","volume":"20","author":"Chiriac","year":"2014","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0023","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/1346-8138.15012","article-title":"Severe psoriasis entering remission after treatment for latent tuberculosis with isoniazid: report of two cases","volume":"46","author":"Partarrieu-Mej\u00edas","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.03.017_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mehy.2018.06.006","article-title":"Tuberculosis-related type of psoriasis","volume":"117","author":"Tsankov","year":"2018","journal-title":"Med Hypotheses"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:04:01Z","timestamp":1747739041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0738081X25001117"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.03.017","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis and psoriasis: Is there a link between them?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}